Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Design and analysis of crossover trials for investigating high-risk medical devices: A review

Contemporary Clinical Trials Communications(2022)10.1016/j.conctc.2022.101004Source: DataRank Database

Design and analysis of crossover trials for investigating high-risk medical devices: A review is a research paper published in Contemporary Clinical Trials Communications (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: goldTopics (12)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Jing Guo ORCID,Hui Zhang ORCID,Bo Zhang ORCID

Live enrichment

PubMed:36164356 PMC:PMC9508509

Robert H. Lurie Comprehensive Cancer Center

Grant: P30CA060553

National Institutes of Health

Grant: P50CA221747

National Institutes of Health

Grant: 5P30AG013854-05

CORE--CLINICAL

National Institutes of Health

Grant: 5P50CA221747-02

SPORE for Translational Approaches to Brain Cancer

National Institutes of Health

Grant: 5P30CA060553-12

The Robert H.Lurie Comprehensive Cancer Center

goldLicense: cc-by-nc-nd

publisherhttps://www.sciencedirect.com/science/article/pii/S2451865422001211/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2451865422001211?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2451865422001211?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9508509

repositoryhttps://doaj.org/article/8013199360644e30a456c735fe57e867

Fields of Study

03 medical and health sciences0302 clinical medicine0101 mathematics01 natural sciences

Keywords

U.s. Food And Drug AdministrationDiabetes TreatmentMedical Device RegulationClass-Iii Medical DevicesCrossover Clinical TrialsMedicine (General)R5-920Article

Sustainable Development Goals

SDG 3: 3. Good health